↓ Skip to main content

Safety and effectiveness of adalimumab in a clinical setting that reflects Canadian standard of care for the treatment of rheumatoid arthritis (RA): Results from the CanACT study

Overview of attention for article published in BMC Musculoskeletal Disorders, November 2011
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
73 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Safety and effectiveness of adalimumab in a clinical setting that reflects Canadian standard of care for the treatment of rheumatoid arthritis (RA): Results from the CanACT study
Published in
BMC Musculoskeletal Disorders, November 2011
DOI 10.1186/1471-2474-12-261
Pubmed ID
Authors

Boulos Haraoui, Alfred Cividino, Jacqueline Stewart, Benoît Guérette, Edward C Keystone

Abstract

This multicenter, open-label, prospective, single cohort study evaluated the effectiveness and safety of adalimumab in a clinical setting reflecting the Canadian standard of care for the treatment of patients with rheumatoid arthritis (RA).

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 73 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
Colombia 1 1%
Unknown 71 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 9 12%
Student > Master 9 12%
Researcher 8 11%
Other 7 10%
Student > Postgraduate 6 8%
Other 16 22%
Unknown 18 25%
Readers by discipline Count As %
Medicine and Dentistry 31 42%
Pharmacology, Toxicology and Pharmaceutical Science 6 8%
Immunology and Microbiology 3 4%
Agricultural and Biological Sciences 3 4%
Nursing and Health Professions 2 3%
Other 8 11%
Unknown 20 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 November 2011.
All research outputs
#15,238,442
of 22,656,971 outputs
Outputs from BMC Musculoskeletal Disorders
#2,440
of 4,024 outputs
Outputs of similar age
#161,874
of 238,843 outputs
Outputs of similar age from BMC Musculoskeletal Disorders
#53
of 65 outputs
Altmetric has tracked 22,656,971 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,024 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.0. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 238,843 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 65 others from the same source and published within six weeks on either side of this one. This one is in the 9th percentile – i.e., 9% of its contemporaries scored the same or lower than it.